PCRX · Insider trading · 13F holders · Congress trades
Pacira BioSciences, Inc. (PCRX)
Who is buying and selling PCRX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 7
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $289K
- Congress trades, 12 months
- 10
PCRX at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 2 PCRX insiders filed 2 sales worth $289K on SEC Form 4, and no open-market purchases; 2 of the sales were pre-planned under Rule 10b5-1.
- 7 13F filers hold PCRX among their 50 largest positions, worth $118.2M combined. The biggest bets by portfolio weight are Doma Perpetual Capital Management LLC (16.4%), Gagnon Advisors, LLC (5.7%) and Gagnon Securities LLC (3.0%). In their latest 13Fs, 1 manager opened a new position and 1 added to one.
- Members of Congress have disclosed 10 PCRX trades since 2019, 10 purchases and 0 sales in the past year; the latest was Tom Malinowski (D-NJ), buying $1K–15K on Jan 25, 2021.
- PCRX last closed at $36.39 on Oct 29, 2026.
PCRX insider trading
Between Aug 1, 2026 and Oct 29, 2026, 2 PCRX insiders filed 2 sales worth $289K on SEC Form 4, and no open-market purchases; 2 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Riker Lauren | Senior Vice President, Finance | Sale10b5-1 | 6,000 | $36.32 | $218K | SEC |
| Aug 18, 2026 | Slonin Jonathan | Chief Medical Officer | Sale10b5-1 | 3,040 | $23.23 | $71K | SEC |
Who owns PCRX? Hedge funds and superinvestors
7 13F filers hold PCRX among their 50 largest positions, worth $118.2M combined. The biggest bets by portfolio weight are Doma Perpetual Capital Management LLC (16.4%), Gagnon Advisors, LLC (5.7%) and Gagnon Securities LLC (3.0%). In their latest 13Fs, 1 manager opened a new position and 1 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Doma Perpetual Capital Management LLCHedge fund | 16.4% | $70.5M | 2,777,794 | +0.0% shares | Q2 2026 |
| Gagnon Securities LLCWealth manager | 3.0% | $15.4M | 608,617 | -1.4% shares | Q2 2026 |
| Gagnon Advisors, LLCHedge fund | 5.7% | $8.9M | 352,637 | +0.0% shares | Q2 2026 |
| Bridge City Capital, LLCInstitutional asset manager | 1.8% | $8.8M | 352,738 | +12.9% shares | Q3 2026 |
| Easterly Investment Partners LLCAsset manager | 0.4% | $8.6M | 337,019 | +0.6% shares | Q2 2026 |
| Coppell Advisory Solutions LLCWealth manager | 0.5% | $5.6M | 16 | New | Q2 2026 |
| Lion Point Capital, LPHedge fund | 1.6% | $342K | 13,500 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 6). Screen PCRX in the grand portfolio →
PCRX stock trades by members of Congress
Members of Congress have disclosed 10 PCRX trades since 2019, 10 purchases and 0 sales in the past year; the latest was Tom Malinowski (D-NJ), buying $1K–15K on Jan 25, 2021.
| Filed | Member | Trade | Amount | Traded | Since |
|---|---|---|---|---|---|
| Aug 26, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Jan 25, 2021 | -47.9% |
| Aug 26, 2021 | Tom MalinowskiD-NJ · House | Buy | $15K–50K | May 31, 2019 | -16.4% |
| Jun 23, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | May 6, 2021 | -42.4% |
| Jun 12, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Apr 20, 2021 | -41.9% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Jan 15, 2021 | -50.6% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Nov 2, 2020 | -30.8% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $15K–50K | Sep 26, 2019 | -8.7% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $1K–15K | Aug 23, 2019 | -0.4% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $15K–50K | May 31, 2019 | -16.4% |
| Mar 5, 2021 | Tom MalinowskiD-NJ · House | Buy | $15K–50K | May 30, 2019 | -18.1% |
PCRX questions and answers
Are insiders buying PCRX stock?
Between Aug 1, 2026 and Oct 29, 2026, 2 PCRX insiders filed 2 sales worth $289K on SEC Form 4, and no open-market purchases; 2 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own PCRX?
7 13F filers hold PCRX among their 50 largest positions, worth $118.2M combined. The biggest bets by portfolio weight are Doma Perpetual Capital Management LLC (16.4%), Gagnon Advisors, LLC (5.7%) and Gagnon Securities LLC (3.0%). In their latest 13Fs, 1 manager opened a new position and 1 added to one.
Has Congress traded PCRX?
Members of Congress have disclosed 10 PCRX trades since 2019, 10 purchases and 0 sales in the past year; the latest was Tom Malinowski (D-NJ), buying $1K–15K on Jan 25, 2021.
Who is the largest holder of PCRX?
Among 13F filers, Doma Perpetual Capital Management LLC reports the largest PCRX position, $70.5M (2,777,794 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Doma Perpetual Capital Management LLC's: 16.4% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.